PERCUROS BV
- Country
- Netherlands
- Type
- Beneficiary
- Website
- www.percuros.com
- Grants received
- 27
Funding record
- 27 grants on record
- €7,287,551.57 awarded in total
- 2008–2022 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
24 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- ACADEMISCH ZIEKENHUIS LEIDEN
- ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
- TECOBIOSCIENCES GMBH
- UNIVERSITA DEGLI STUDI DI CAMERINO
- MEDRES-MEDICAL RESEARCH GMBH
- MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
- PROGREDUM GMBH
- UNIVERSITEIT MAASTRICHT
Calls from this organisation
No published calls from this organisation.
Grants received
- Distributed and federated cross-modality actuation through advanced nanomaterials and neuromorphic learning
- A gel-network depot for bringing advance strategies for skin cancer
- Nanoparticle-Based Imaging and Therapy of Chronic Pain in the Dorsal Root Ganglia (DRG)
- Bioengineered exosomes based approaches for the effective treatment of non-small cell lung cancer
- evolutionary platform to predict breast cancer (BC) patients outcome and response to therapy
- Biosafety assays for the diagnosis and prediction of drug-related complement pathology
- Innovative tools to detect Glioblastoma (GBM) exosomes
- Staff Exchange for Novel applications in 19f magnetic resonance imaging
- DevelOpmeNt of Cancer RNA TherapEutics
- proactive monitoring of cancer as an alternative to surgery
- Critical solutions for elderly well-being
- Novel Applications in 19F Magnetic Resonance Imaging
- A nanovaccine Approach for the treatment of Pancreatic Cancer
- Site-selective protein-modification chemistries for antibody-drug conjugates (ADCs)
- Biodegradable fluorescent nanoprobes for early detection of (pre)malignant lesions of the gastrointestinal tract
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.